Eli Lilly wins China approval for weight-loss pill orforglipron
China weight-loss pill approval for Eli Lilly's orforglipron puts it ahead of Novo Nordisk, Pfizer and Innovent in the country's obesity market.
Topic
LLY
Every Financial News story tagged LLY, newest first.
- Stories
- 3
- Last updated
- Follow
- RSS feed
All stories
1–3 of 3
Adlai Nortye lines up Lilly, Merck KGaA for AN4035 trial
Adlai Nortye clinical collaboration with Lilly and Merck KGaA will test AN4035 plus cetuximab, as ANL shares trade 26% below their 20-day high.
FDA approval for Lilly’s weekly insulin Onswik, shares dip
Onswik FDA approval: Eli Lilly's once-weekly insulin wins US clearance for type 2 diabetes, but LLY shares slipped on the day.
